Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Issue of Equity

13 Aug 2009 08:30

RNS Number : 3763X
J.P. Morgan Private Equity Ltd
13 August 2009
Β 

ο»Ώ

J.P.Β Morgan Private EquityΒ Exceeds Fundraising TargetΒ 

Β * * *

GUERNSEY,Β 13Β AUGUSTΒ 2009Β 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company"), the London Stock Exchange listed private equity secondary fund,Β announces that it has exceededΒ the Company's initialΒ fundraisingΒ target byΒ over 50%.Β  Through a series of closings in July and August, JPEL has raised over $75Β million.Β Β Β 

"WeΒ believe that the overwhelming support for the fundraising from our existing shareholdersΒ and new JPEL investors is a vote of confidenceΒ forΒ opportunities available in theΒ secondary private equity market," said JPELΒ ChairmanΒ Trevor Ash. "Most of this capital was raised at a premium to the stock priceΒ whileΒ the JPEL share price rebounded by 30.6%Β in the quarter ending June 30th,Β further demonstrating the market's faith in our strategy."Β 

"We started meeting with existing and potential new shareholders in June, with an initial fundraising target of $50 million. With current funds raised at over $75 million, JPEL has received aΒ strongΒ response from investors." said Gregory Getschow, JPEL's portfolio manager. "WeΒ nowΒ have significantΒ fresh capitalΒ to invest, and intend toΒ useΒ it in a way to drive NAV growth."

"We look forward to investing in what we hope to be accretive secondary investmentsΒ thatΒ generate value for our shareholders." commented Troy Duncan, JPEL's portfolio manager. "We believe that the current market for secondary private equity investments represents a significant opportunity for JPEL to deploy capital at favourable valuations."

JPELΒ closed at $1.01 perΒ US$ Equity ShareΒ on 11 August 2009,Β representingΒ aΒ 24.6%Β discount toΒ 30 June 2009Β NAV, approximatelyΒ 25Β percentage points narrower than the average discount ofΒ 50%Β experienced by its peer group ofΒ listed private equityΒ fund of funds.

JPEL's primary strategy is to acquire secondary market portfolios of direct fund investments, significantly invested partnership interests and partially drawn commitments, in order toΒ accelerateΒ NAV development.Β JPEL employs an opportunistic, deep value private equity investment strategy and focuses on value-oriented investments with potential for early return of capital. FromΒ inceptionΒ through 30 June 2009, JPEL'sΒ NAVΒ per US$ EquityΒ Share has grownΒ 31.4%Β from $1.02Β at inceptionΒ versus declines ofΒ 22.8%, 16.1%Β andΒ 58.3%Β in the S&P 500, MSCI World Index (USD)Β Β and LPX indices, respectively.

The Company has also announced that it will issue warrants free of subscription cost to shareholders on record as atΒ 17 August 2009. OneΒ warrant will be issued for everyΒ sixΒ US$ Equity Shares owned. The warrants will be publicly traded on the London Stock Exchange, subject to all regulatory approvals and theΒ strikeΒ price will be based on the Company's unaudited estimated 30 June 2009Β NAVΒ per US$ Equity ShareΒ plus a premium.

Β * * *

Β Β 

About J.P. Morgan Private Equity LimitedΒ 

J.P. Morgan Private Equity Limited is aΒ GuernseyΒ registered and incorporated, London Stock Exchange-listed, closed-ended investment companyΒ (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.Β Β The Company's capital structure consists of three classes of shares: Equity Shares and two classes of Zero Dividend Preference Shares due 2013 and 2015, respectively.

Applications have been made to the UK Listing Authority for the Warrants to be admitted to the OfficialΒ List and to the London Stock Exchange forΒ theΒ Warrants to be admitted to trading on its main marketΒ under the symbol "JPWW".

J.P. Morgan Private Equity Limited

Troy Duncan / Gregory Getschow

Telephone: +44 (0) 20 7742 3032 / +1 212 648 1150

Peregrine Communications

Anthony Payne / Paul Mungo

Telephone: +44 (0) 20 3178 6869 / +44 (0)20 7822 2307

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOECKNKBOBKKOFD
Date   Source Headline
2nd Jun 20269:29 amRNSNet Asset Value - March 2026
23rd Apr 20267:00 amRNSJoint Broker Appointment
14th Apr 20267:00 amRNSAppointment of Directors
6th Mar 20265:59 pmRNSHalf-year Financial Report - December 2025
14th Jan 20269:53 amRNSCOMPLETION OF THIRTEENTH MANDATORY REDEMPTION
29th Dec 20253:18 pmRNSTHIRTEENTH MANDATORY REDEMPTION
19th Dec 20255:53 pmRNSNet Asset Value September 2025
2nd Dec 20254:44 pmRNS2025 AGM Results Statement
10th Nov 202512:19 pmRNS2025 AGM Circular Statement
5th Nov 20254:07 pmRNSHolding(s) in Company
3rd Nov 20254:30 pmRNSHolding(s) in Company
3rd Nov 20254:11 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNSAnnual Financial Report 2025
22nd Jul 20257:00 amRNSAppointed Sole Corp. Broker & Financial Adviser
10th Jun 20254:47 pmRNSNet Asset Value - March 2025
1st May 20256:11 pmRNSHolding(s) in Company
18th Mar 20255:04 pmRNSHalf-year Report - December 2024
3rd Dec 20242:30 pmRNSNet Asset Value September 2024
27th Nov 20245:16 pmRNS2024 AGM Results
6th Nov 20247:00 amRNS2024 AGM Circular
25th Oct 20247:00 amRNSPortfolio Update
25th Oct 20247:00 amRNSAnnual Financial Report - 2024
5th Jun 20247:00 amRNSNet Asset Value - March 2024
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.